DaVita HealthCare Partners Inc (DVA)
Cash ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 794,933 | 1,070,780 | 416,493 | 345,131 | 380,063 | 449,458 | 327,443 | 317,132 | 244,086 | 367,510 | 262,605 | 327,502 | 461,900 | 1,045,740 | 1,043,630 | 884,205 | 324,958 | 710,514 | 2,928,910 | 1,381,760 |
| Short-term investments | US$ in thousands | 135,788 | 75,836 | 73,165 | 53,948 | 56,111 | 53,735 | 55,966 | 129,447 | 184,708 | 177,134 | 230,533 | 71,678 | 79,135 | 86,978 | 107,179 | 54,011 | 72,395 | 68,587 | 336,570 | 53,409 |
| Total current liabilities | US$ in thousands | 2,973,410 | 2,943,990 | 2,994,790 | 2,583,100 | 2,642,210 | 2,537,930 | 2,403,420 | 2,565,090 | 2,619,750 | 2,537,410 | 2,310,750 | 2,420,450 | 2,398,530 | 2,363,050 | 2,386,040 | 2,314,720 | 2,476,140 | 2,499,240 | 4,274,560 | 2,220,750 |
| Cash ratio | 0.31 | 0.39 | 0.16 | 0.15 | 0.17 | 0.20 | 0.16 | 0.17 | 0.16 | 0.21 | 0.21 | 0.16 | 0.23 | 0.48 | 0.48 | 0.41 | 0.16 | 0.31 | 0.76 | 0.65 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($794,933K
+ $135,788K)
÷ $2,973,410K
= 0.31
The cash ratio of DaVita HealthCare Partners Inc has exhibited fluctuations over the period from March 31, 2020, to December 31, 2024. The cash ratio indicates the company's ability to cover its short-term liabilities with its cash and cash equivalents.
The cash ratio started at 0.65 on March 31, 2020, showing that for every dollar of short-term liabilities, the company had $0.65 in cash and cash equivalents. The ratio increased to 0.76 by June 30, 2020, indicating an improvement in liquidity position. However, the ratio dropped significantly to 0.16 by December 31, 2020, which suggests a potential liquidity strain.
From March 31, 2021, the cash ratio gradually increased to 0.48 by June 30, 2021, and remained steady until September 30, 2022. This stability may indicate prudent cash management practices during this period.
However, the ratio declined to 0.15 by March 31, 2024, indicating a reduction in the company's ability to cover short-term obligations with readily available cash. The cash ratio recovered slightly to 0.31 by December 31, 2024, suggesting an improvement in liquidity compared to the earlier quarter.
Overall, the fluctuating cash ratio of DaVita HealthCare Partners Inc over the analyzed period indicates varying levels of liquidity and highlights the importance of monitoring cash reserves to meet short-term obligations effectively.
Peer comparison
Dec 31, 2024